MedXCell SA is proud to announce the arrival of Andrew Galazka and John D. McMannis as new members of the Board and Pierre J.Magistretti as new scientific advisor
Montreux, Switzerland | March 11, 2022 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and